The role of nuclear medicine in modern therapy of cancer
- PMID: 22446937
- DOI: 10.1007/s13277-012-0373-8
The role of nuclear medicine in modern therapy of cancer
Abstract
Nuclear medicine is a multidisciplinary field that develops and uses instrumentation and tracers (radiopharmaceuticals) to study physiological processes and noninvasively diagnose, stage, and treat diseases. Particularly, it offers a unique means to study cancer biology in vivo and to optimize cancer therapy for individual patients. A tracer is either a radionuclide alone, such as iodine-131 or a radiolabel in a carrier molecule such as (18)F in fluorodeoxyglucose ((18)F-FDG), or other feasible radionuclide attached to a drug, a protein, or a peptide, which when introduced into the body, would accumulate in the tissue of interest. Nuclear medicine imaging, including single-photon emission computer tomography and positron emission tomography, can provide important quantitative and functional information about normal tissues or disease conditions, in contrast to conventional, anatomical imaging techniques such as ultrasound, computed tomography, or magnetic resonance imaging. For treatment, tumor-targeting agents, conjugated with therapeutic radionuclides, may be used to deposit lethal radiation at tumor sites. This review outlines the role of nuclear medicine in modern cancer therapy.
Similar articles
-
Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. doi: 10.1967/s002449910713. Epub 2018 Mar 20. Hell J Nucl Med. 2018. PMID: 29550853
-
Nuclear medicine: from photons to physiology.Curr Pharm Des. 2003;9(11):903-16. doi: 10.2174/1381612033455224. Curr Pharm Des. 2003. PMID: 12678874 Review.
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
[Nuclear medicine in vivo and functional imaging. Historical perspective].Bull Acad Natl Med. 1996 Jan;180(1):131-40; discussion 140-1. Bull Acad Natl Med. 1996. PMID: 8696871 French.
-
The development of nuclear medicine in Finland: a review on the occasion of the 40th anniversary of the Finnish Society of Nuclear Medicine.Clin Physiol. 2000 Sep;20(5):317-29. doi: 10.1046/j.1365-2281.2000.00267.x. Clin Physiol. 2000. PMID: 10971542 Review. No abstract available.
Cited by
-
Actinium chelation and crystallization in a macromolecular scaffold.Nat Commun. 2024 Jul 15;15(1):5741. doi: 10.1038/s41467-024-50017-5. Nat Commun. 2024. PMID: 39009580 Free PMC article.
-
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.
-
Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents.Int J Nanomedicine. 2023 Aug 3;18:4449-4470. doi: 10.2147/IJN.S416737. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37555189 Free PMC article. Review.
-
SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.Pharmaceuticals (Basel). 2023 Mar 10;16(3):423. doi: 10.3390/ph16030423. Pharmaceuticals (Basel). 2023. PMID: 36986521 Free PMC article.
-
Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges.Molecules. 2022 Aug 16;27(16):5231. doi: 10.3390/molecules27165231. Molecules. 2022. PMID: 36014472 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources